26 Jul 2017
Author(s): 
Lee SM, Wu CK, Plieskatt JL, Miura K, Hickey JM, King CR

This article, published in Clinical and Vaccine Immunology, reports on the immunogenic potential of the N-terminal Plasmodium falciparum sexual-stage antigen (Pfs230C1) as a component of an effective transmission-blocking vaccine. According to the authors' findings, this antigen was shown to induce antibodies in mice that exhibited functional activity as determined by two assays, supporting the continued advancement of the Pfs230C1 antigen as a component of a transmission-blocking vaccine and the continued use of the scalable baculovirus expression system for generation of complex malaria proteins.